Tag Archives: epidermal growth factor

STAT3 as a possible new drug target for polycystic kidney disease

Two discoveries at UC Santa Barbara point to potential new drug therapies for patients with kidney disease. The findings are published in this week’s issue of the Proceedings of the National Academy of Sciences. Over 600,000 people in the U.S., … Continue reading

Posted in M Loghman-Adham, MD | Tagged , , | Leave a comment